Business Context and Reporting Period
Envista Holdings Corporation filed a Form 8-K dated November 30, 2021, reporting a board appointment effective December 1, 2021. The filing is a corporate governance update and does not report operating results for a specific financial period.
Key Financial Metrics and Liquidity
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material Changes
- Barbara B. Hulit was appointed as a Class I director and as a member of Envista’s Audit Committee, effective December 1, 2021.
- The Board determined that Ms. Hulit is independent under New York Stock Exchange listing standards and satisfies the applicable audit committee independence requirements under Rule 10A-3.
- Ms. Hulit is Senior Vice President of Fortive Corporation and President and CEO of Fortive’s Advanced Healthcare Solutions.
Compensation, Outlook, and Risks
- Ms. Hulit is eligible for Envista’s standard non-employee director annual retainer, prorated for the remainder of fiscal 2021, along with standard equity awards and expense reimbursement.
- She entered into Envista’s standard form of director indemnification agreement.
- The filing states that there was no arrangement or understanding with another person regarding her selection and no related-party transaction requiring disclosure under Item 404(a) of Regulation S-K.
- The filing provides no management guidance, outlook, contingencies, unusual financial items, or additional risk disclosures.
Investor Verification Points
- Verify the effect of Ms. Hulit’s appointment on the composition and independence of the Board and Audit Committee.
- Review Envista’s 2021 proxy statement for the applicable non-employee director compensation arrangements.
- Review subsequent filings for any changes to Ms. Hulit’s board role, committee membership, or compensation.